Clinical Trials Logo
  1. Home
  2. Crow's Feet
  3. NCT01124552

A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles Clinical Trial

Official title:
A Phase 2, Double-Blind, Randomized, 4-Arm, Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a Single Dose of RT001 Topical Gel for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Clinical Trial Summary

The purpose of this study is to find out if an investigational drug, called RT001 Topical Gel, is safe and useful in minimizing the wrinkles between the eye and hairline called lateral canthal lines, also known as crow's feet wrinkles.

Clinical Trial Description

RT001, a new drug, may be effective for the temporary improvement in the appearance of moderate to severe lateral canthal lines (crow's feet wrinkles) in adults. In this study, researchers want to find out if RT001 is more effective than three comparator groups by examining the effect on the improvement of crow's feet by both the patient and physician. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01124552
Study type Interventional
Source Revance Therapeutics, Inc.
Contact
Status Completed
Phase Phase 2
Start date April 2010
Completion date July 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01447342 - A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines Phase 2/Phase 3
Completed NCT00978887 - Retorna Facial Cream in the Treatment of Facial Wrinkles Phase 3
Completed NCT00414544 - Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds Phase 2
Completed NCT00888914 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Completed NCT00877279 - Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft Phase 3
Completed NCT01124565 - Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT00922623 - Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI N/A
Not yet recruiting NCT03836638 - The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment N/A
Not yet recruiting NCT06322875 - A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection N/A
Completed NCT01566396 - Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles N/A
Completed NCT01151436 - Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers N/A
Completed NCT06321770 - Oral Supplementation With Active Collagen Peptides and Skin Health Improvement N/A
Completed NCT01379365 - Cryo-Touch III Refinement Study Investigational Plan Phase 2/Phase 3
Completed NCT00288470 - A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast. N/A
Completed NCT02122536 - Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles N/A
Completed NCT01167140 - Cryo-Touch II for the Treatment of Wrinkles Phase 2/Phase 3
Completed NCT00968825 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Completed NCT03286283 - The Use of J-Plasma® for Dermal Resurfacing N/A
Completed NCT01064518 - Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT00417469 - A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs) Phase 3